MEX3A and pancreatic ductal adenocarcinoma: Recently, MEX3A has been reported as a novel biomarker promoting proliferation and migration in various cancers such as pancreatic ductal adenocarcinoma (PDA), liver cancer, and colorectal cancer [6–8]; yet, its role in OC is still unclear.